10-K/A XBRL

AMENDMENT NO. 1 TO FORM 10-K

Company: Orchestra BioMed Holdings, Inc.
Filed: March 31, 2022
Period of Report: December 31, 2020
Accession Number: 0001213900-22-016826

View Document ↗ View on SEC.gov ↗